Nasdaq (Nasdaq: NDAQ) notified Pitanium Limited (Nasdaq: PTNM) that its securities are expected to be delisted from the Nasdaq Stock Market on July 16, 2026, unless the company appeals. Trading in Pitanium shares remains halted and may move to the over-the-counter market after delisting.
Loading...
Loading translation...
Positive
None.
Negative
Pitanium securities face Nasdaq delisting effective July 16, 2026 unless appealed
Pitanium trading halted since October 18, 2025 and remains unavailable
Post-delisting, Pitanium shares may only trade in over-the-counter market
News Market Reaction – NDAQ
-2.36%
-2.36%News Effect
On the day this news was published, NDAQ declined 2.36%, reflecting a moderate negative market reaction.
Nasdaq’s decision to delist Pitanium Limited, citing IM-5101-4 after an SEC trading suspension, unde...
Analysis
Nasdaq’s decision to delist Pitanium Limited, citing IM-5101-4 after an SEC trading suspension, underscores its willingness to remove problematic issuers; investors may watch whether similar actions increase and how often such enforcement news aligns with NDAQ’s share moves.
Announced SpaceX addition to the Nasdaq-100 Index on a specified date.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Pattern Detected
Recent NDAQ news has produced mixed share reactions, with both aligned and divergent moves around operational and listing-related announcements.
Key Terms
listing qualifications hearings panel, over-the-counter market, u.s. securities and exchange commission, im-5101-4
4 terms
listing qualifications hearings panelregulatory
"unless the company appeals to a Listing Qualifications Hearings Panel."
A listing qualifications hearings panel is a review board at a stock exchange that evaluates whether a company still meets the exchange’s rules for being listed, such as minimum share price, financial reporting, or governance standards. Think of it as a referee deciding if a team can stay in the league; its decisions can affect a stock’s ability to trade on the exchange, liquidity, investor confidence, and ultimately share value.
over-the-counter marketregulatory
"the securities may be eligible for trading in the over-the-counter market."
A market where securities are bought and sold directly between dealers and brokers instead of on a centralized stock exchange. Think of it like a neighborhood bazaar compared with a big supermarket: prices and rules can vary, oversight is lighter, and some instruments are harder to trade or riskier. Investors care because OTC listings can offer access to small or specialized investments but often come with higher price volatility, lower liquidity, and greater information risk.
u.s. securities and exchange commissionregulatory
"a temporary trading suspension in the Company’s securities by the U.S. Securities and Exchange Commission"
The U.S. Securities and Exchange Commission is a government agency responsible for overseeing the stock market and protecting investors. It sets rules to ensure that companies share truthful information and that trading is fair, helping to maintain trust in the financial system. This oversight is important because it helps prevent fraud and ensures that investors can make informed decisions.
im-5101-4regulatory
"determined that it is appropriate to use its authority under IM-5101-4 to delist"
An investigational product code name for a drug or medical therapy under development and testing. Think of it as a prototype being evaluated in clinical studies to prove it works and is safe; positive or negative trial results, safety findings, or regulatory decisions about it can materially affect the developer’s future revenue prospects and share price. Investors watch such codes because they signal potential new products, timelines to market, and the level of scientific and regulatory risk involved.
NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified Pitanium Limited (Nasdaq: PTNM) that its securities will be delisted from the Nasdaq Stock Market LLC on July 16, 2026, unless the company appeals to a Listing Qualifications Hearings Panel.The securities will remain halted, and unavailable to trade, until any appeal is resolved.Following removal from Nasdaq the securities may be eligible for trading in the over-the-counter market.
Following a temporary trading suspension in the Company’s securities by the U.S. Securities and Exchange Commission (https://www.sec.gov/files/litigation/suspensions/2025/34-104165-ts.pdf) Nasdaq halted trading in the Company’s ordinary shares on October 18, 2025.Nasdaq has now determined that it is appropriate to use its authority under IM-5101-4 to delist the Company’s securities from Nasdaq.
For news and additional information about the company, please review the companies’ public filings or contact the company directly.
Why is Pitanium Limited (NASDAQ: PTNM) being delisted from Nasdaq (NDAQ)?
Pitanium faces delisting because Nasdaq determined it appropriate to use its authority under IM-5101-4. According to Nasdaq, this follows an SEC temporary trading suspension and a subsequent trading halt in Pitanium’s ordinary shares starting October 18, 2025.
When will Pitanium Limited (PTNM) be delisted from the Nasdaq Stock Market?
Pitanium’s securities are scheduled for delisting from Nasdaq on July 16, 2026, unless the company appeals. According to Nasdaq, trading will stay halted and unavailable until any appeal to a Listing Qualifications Hearings Panel is fully resolved.
Can Pitanium Limited (PTNM) appeal its anticipated Nasdaq delisting?
Yes, Pitanium can appeal the anticipated delisting to a Nasdaq Listing Qualifications Hearings Panel. According to Nasdaq, the securities will remain halted and cannot trade on Nasdaq while any appeal is pending, with delisting effective July 16, 2026 if no successful appeal occurs.
What happens to Pitanium Limited stock after it is delisted from Nasdaq?
After removal from Nasdaq, Pitanium’s securities may be eligible for over-the-counter market trading. According to Nasdaq, this potential OTC trading would occur following the effective delisting date, as the shares will no longer be listed on the Nasdaq Stock Market.
Why has trading in Pitanium Limited (PTNM) been halted since October 18, 2025?
Trading was halted after a temporary trading suspension in Pitanium’s securities by the U.S. SEC. According to Nasdaq, it halted trading in the company’s ordinary shares on October 18, 2025 and has kept them halted during the delisting process.
Where can investors find Nasdaq rules on delisting, including IM-5101-4 and Rule 5800 Series?
Investors can review Nasdaq’s delisting rules, including IM-5101-4 and the Rule 5800 Series, on Nasdaq’s website. According to Nasdaq, the complete rulebook is available at its online Listing Center, which explains procedures and standards for delisting securities.
